BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/28/2014 8:35:00 AM | Browse: 1097 | Download: 1073
Publication Name World Journal of Cardiology
Manuscript ID 8557
Country/Territory Slovenia
Received
2013-12-30 11:58
Peer-Review Started
2013-12-30 12:01
To Make the First Decision
2014-02-13 15:55
Return for Revision
2014-02-17 19:33
Revised
2014-03-28 14:45
Second Decision
2014-06-27 17:45
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-27 18:03
Articles in Press
2014-06-27 18:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-25 16:28
Publish the Manuscript Online
2014-09-28 08:35
ISSN 1949-8462 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Genetics & Heredity
Manuscript Type Topic Highlights
Article Title miRNome in myocardial infarction: Future directions and perspective
Manuscript Source Invited Manuscript
All Author List Emanuela Boštjančič and Damjan Glavač
Funding Agency and Grant Number
Corresponding Author Damjan Glavač, PhD, Professor of Human Genetics, Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia. damjan.glavac@mf.uni-lj.si
Key Words MicroRNAs; Myocardial infarction; Human; Animal models; Biomarkers and targets
Core Tip MicroRNAs (miRNAs) contribute to various developmental, physiological and pathological processes in the heart. Cardiac diseases show abnormal miRNA regulation. Primary studies of miRNA involvement in cardiac disease analyzed mainly miRNAs that enriched in or specific for cardiomyocytes; however, growing evidence suggests that other cell-type-specific or ubiquitously expressed miRNAs are also involved in cardiovascular disease. miRNAs were found to contribute to the pathogenesis of myocardial infarction (MI) and post-MI. The majority of studies focused on miRNAs in animal models of MI, in human and animal plasma samples of MI (prognostic and diagnostic targets), and on miRNAs as promising therapeutic targets.
Publish Date 2014-09-28 08:35
Citation Boštjančič E, Glavač D. miRNome in myocardial infarction: Future directions and perspective. World J Cardiol 2014; 6(9): 939-958
URL http://www.wjgnet.com/1949-8462/full/v6/i9/939.htm
DOI http://dx.doi.org/10.4330/wjc.v6.i9.939
Full Article (PDF) WJC-6-939.pdf
Full Article (Word) WJC-6-939.doc
Manuscript File 8557-Review.docx
Answering Reviewers 8557-Answering reviewers.pdf
Copyright License Agreement 8557-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 8557-Language certificate.pdf
Peer-review Report 8557-Peer review(s).pdf
Scientific Misconduct Check 8557-CrossCheck.jpg
Scientific Editor Work List 8557-Scientific editor work list.pdf